Camille Landis, MBA

Venture Partner

Camille Landis is a Venture Partner at Raven, with over twenty years of operating experience growing companies and advancing new medicines for patients. Prior to Raven, she served as Chief Business Officer and Chief Financial Officer at T‑Knife Therapeutics, where she raised capital, executed collaborations, and led multiple business functions, including corporate development, strategic planning, finance, legal, and investor relations. Prior to T‑Knife, Camille served as Senior Vice President of Corporate Development at Unity Biotechnology and Chief Business Officer at Eidos Therapeutics, overseeing business development, strategic planning, and financing activities. Earlier in her career, she was Vice President of Corporate Development at Relypsa, where she led the sale process resulting in the company’s $1.5 billion acquisition by Galenica and supported its IPO and financing activities. Camille also led corporate development efforts at Affymax and held roles of increasing responsibility across finance, business development, and commercial operations. She began her career in investment banking with Piper Jaffray’s healthcare practice and in strategy consulting with Navigant Consulting’s biotechnology team. Camille holds a BS in Biology from the University of St. Thomas and an MBA from the Haas School of Business at the University of California, Berkeley.